Considering the association of elevated HCY levels with PD risk of PD, supplementation of vitamin B6 and B12 is recommended for patients on a long-term levodopa/dopa decarboxylase inhibitor (DDI) regimen (Phokaewvarangkul et al., 2023). Here, DDC is linked to Parkinson disease.